These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12091763)
1. Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia. Tong LM; Mendez MN Prog Cardiovasc Nurs; 2002; 17(3):142-7. PubMed ID: 12091763 [No Abstract] [Full Text] [Related]
2. Heparin-induced thrombocytopenia: a review of current pharmacologic treatment. Talati R; Colemen CI; White CM Conn Med; 2008 May; 72(5):275-9. PubMed ID: 18593063 [No Abstract] [Full Text] [Related]
3. [Prevention and treatment of deep vein thrombosis with ximelagatran]. Caspary L; Bauersachs R; Brehme S; Creutzig A; Harenberg J; Hoffmann U; Landgraf H; Schellong S Dtsch Med Wochenschr; 2004 Jul; 129(30):1635-40. PubMed ID: 15257504 [No Abstract] [Full Text] [Related]
4. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin. Lubenow N; Greinacher A J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194 [No Abstract] [Full Text] [Related]
5. Comment: treatment of heparin-induced thrombocytopenia. Smythe MA; Warkentin TE Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076 [No Abstract] [Full Text] [Related]
6. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin. Warkentin TE Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128 [No Abstract] [Full Text] [Related]